Evidence map›Paper›PMID 29844136›Full record

ArticleThe Journal of general physiology2018

A novel high-affinity inhibitor against the human ATP-sensitive Kir6.2 channel.

Yajamana Ramu, Yanping Xu, Zhe Lu

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of general physiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Inhibition Mechanism of Pancreatic KResearch (Washington, D.C.) · 2026
    Article
  2. Review
  3. Personalized Therapeutics for KAnnual review of pharmacology and toxicology · 2023
    Review
  4. Review
  5. Kir6.1 and SUR2B in Cantú syndrome.American journal of physiology. Cell physiology · 2022
    Review
  6. Article
  7. Development of IFrontiers in pharmacology · 2021
    Article
  8. Review
  9. Peptide Toxins Targeting KV Channels.Handbook of experimental pharmacology · 2021
    Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Yajamana RamuDepartment of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Yanping XuDepartment of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Zhe LuDepartment of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA zhelu@pennmedicine.upenn.edu.ORCID 0000-0001-7108-9303
University of Pennsylvania · US

Funding

Development of novel means to stimulate Ca2+-dependent exocytotic secretionR01DK109979 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI LU, ZHE · 2016 to 2019
$1.6M
NIDDK NIH HHS R01 DK109979
6 · The paper itself

Abstract

The adenosine triphosphate (ATP)-sensitive (K

Indexed as

AnimalsArthropodsArthropod VenomsBinding SitesHumansKcnj11 ChannelPotassium Channel BlockersPotassium Channels, Inwardly RectifyingProtein BindingXenopusArthropod VenomsKcnj11 ChannelPotassium Channel BlockersPotassium Channels, Inwardly Rectifying

Identifiers

PMID29844136
PMCPMC6028498
OpenAlexW2805531923

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.